Good point re MedItalia & GMPatch, U$35/dayCompany...

Good point re MedItalia & GMPatch, U$35/day

Company Presentation

page 11
IDTF is charging U$54 to $69 a month, for non-Prizma services.

Looks like *U$75 a month for Prizma* is too far fetched.


p8
Nasdaq valuation will be forward looking:
I mean after gmed has scored a pattern of 1-3 months of revenues in May-June-July, then IPO mgrs will do dd on Gyimei production capacity (1m.1.5m,2m?), margins,monthly subs fees, MOUs, and if they are pre-sold to Italy, USA, Taiwan, China. etc

'Nasdaq valuation will be forward looking'
for e.g.,
IRTC
U$147m, last 12 month revenue:

What i mean is - *If* IRTC fwd looking revenue nforext 12 months is:
$50m?
$100m?
$150m?
$200m?
$300m?

Qn:
What is the likely MC today, for each revenue scenarios?hat
Apply these to Gmed


Today:
MC, Revenue, Net income/loss
BEAT
US$1778m, US$399m, US$42.82m
IRTC
US$2359m, US$147m, (-US$48.28)
GMED
?,?,?, in Q3/202


p6
Prizma
B2B channel
Insurance companies
▪Medical institutions
▪Distributors
▪Government partner



Cheers
Ps
p12
Fosun Group (parent of FosunHani, nasd IPO co-mgr) is also active in high-end nursing homes (aka luxurious senior living).
hint hint.